Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-07-18), the Forward Annual Dividend Yield of Shilpa Medicare is 0.08%.
As of today (2026-07-18), the Trailing Annual Dividend Yield of Shilpa Medicare is 0.08%.
BOM:530549's Forward Dividend Yield % is ranked worse than 98.05% of 513
companies
in the Drug Manufacturers industry
Industry Median: 2
vs BOM:530549: 0.08
During the past 3 years, the average Dividends Per Share Growth Rate was -3.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shilpa Medicare was 56.50% per year. The lowest was -19.40% per year. And the median was 21.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Shilpa Medicare Forward Dividend Yield % Related Terms
BOM:530549 vs ZTS, UTHR: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shilpa Medicare Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Shilpa Medicare's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Shilpa Medicare Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 0.500000
2025-09-17
2025-09-17
0000-00-00
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Shilpa Medicare's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.08% mean?
Shilpa Medicare (BOM:530549) has a Forward Dividend Yield % of 0.08% as of Jul. 18, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Shilpa Medicare and its competitors. According to the industry distribution chart, Shilpa Medicare ranks #503 out of 513 companies in the Drug Manufacturers industry, placing it in the top 98.1%.
Is Shilpa Medicare's Forward Dividend Yield % too high?
Shilpa Medicare's current Forward Dividend Yield % is 0.08%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.00. Shilpa Medicare's value of 0.08% is 96% below this industry median. Based on the distribution chart, Shilpa Medicare ranks #503 out of 513 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shilpa Medicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shilpa Medicare ranks #503 out of 513 companies for Forward Dividend Yield %. This places Shilpa Medicare in the lower half of its industry. The industry median Forward Dividend Yield % is 2.00. Shilpa Medicare's value of 0.08% is 96% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.00, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shilpa Medicare's current Forward Dividend Yield % of 0.08% is 96% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Shilpa Medicare and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shilpa Medicare's current Forward Dividend Yield % is 0.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (BOM:530549) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹387.34, compared to a current price of ₹619.55 — trading 59.9% above its estimated fair value. The current Forward Dividend Yield % is 0.08% and 96% below the Drug Manufacturers industry median of 2.00. Shilpa Medicare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Shilpa Medicare (BOM:530549), the current Forward Dividend Yield % is 0.08% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shilpa Medicare (BOM:530549) Overvalued in 2026?
Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued.
The current stock price of ₹619.55 is trading 59.9% above its estimated GF Value™ of ₹387.34.
GuruFocus considers Shilpa Medicare to be Significantly Overvalued.
Key valuation signals for BOM:530549:
Forward Dividend Yield %: 0.08%
GF Value™: ₹387.34 vs. price of ₹619.55 (59.9% above fair value)
Industry Position: 96% below the Drug Manufacturers median (#503 of 513)
No single metric tells the full story. See the BOM:530549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
76GF Score
Get the complete analysis for BOM:530549
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530549 has been successfully added to your 
